Active
Atlas Opportunity Score 90/100
Verified September 18, 2026
UAMS BioVentures
2026 AR Health Ventures Accelerator (ARHVA) – Cohort 3
UAMS BioVentures is accepting Cohort 3 applications from UAMS employees developing therapeutic and health-related technologies. Selected projects may receive up to $50,000 in ARHVA-managed project support for an initial six-month development cycle.
Required next actionAuthoritative BioVentures source rechecked September 18, 2026. The deadline remains September 30, 2026 at 5:00 PM, but BioVentures does not state the applicable time zone. Keep this record unpublished and fail closed for new applicant outreach until the time zone is authoritatively verified with at least 48 hours remaining.